FDG-PET imaging in the management of non-small-cell lung cancer

被引：10
作者：
Salminen, E
Mac Manus, M
机构：
[1] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[2] Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia
来源：
ANNALS OF ONCOLOGY | 2002年 / 13卷 / 03期
关键词：
FDG-PET; non-small-cell lung cancer; outcome; staging; treatment;
D O I：
10.1093/annonc/mdf106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Lung cancer is currently the leading cause of cancer-related death in both men and women in most Western countries. Tumour stage is the strongest prognostic factor and the most important parameter guiding treatment decision making. Metabolic positron emission tomography imaging with fluorodeoxyglucose (FDG-PET) has consistently proved superior to conventional imaging for staging of non-small-cell lung cancer and provides information of greater prognostic significance than can be obtained using conventional approaches. FDG-PET has been approved in the USA. Germany and the UK as a basic and invaluable tool in the management of lung cancer.
引用
收藏
页码：357 / 360
页数：4
相关论文
共 37 条
[1]   Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: Are these carcinomas candidates for video-assisted lobectomy? [J].
Asamura, H ;
Nakayama, H ;
Kondo, H ;
Tsuchiya, R ;
Shimosato, Y ;
Naruke, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (06) :1125-1134
[2]   Metabolic staging of lung cancer. [J].
Berlangieri, SU ;
Scott, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :290-292
[3]  
Bradley J. D., 2000, International Journal of Radiation Oncology Biology Physics, V48, P129, DOI 10.1016/S0360-3016(00)80055-3
[4]   Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer [J].
Bury, T ;
Barreto, A ;
Daenen, F ;
Barthelemy, N ;
Ghaye, B ;
Rigo, P .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1244-1247
[5]   Non-small-cell lung cancer - Stalemate or progress? [J].
Carney, DN ;
Hansen, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17) :1261-1262
[6]  
Dietlein M, 2001, NUKLEARMED-NUCL MED, V40, P122
[7]   Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer [J].
Dunagan, DP ;
Chin, R ;
McCain, TW ;
Case, LD ;
Harkness, BA ;
Oaks, T ;
Haponik, EF .
CHEST, 2001, 119 (02) :333-339
[8]   Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].
Dwamena, BA ;
Sonnad, SS ;
Angobaldo, JO ;
Wahl, RL .
RADIOLOGY, 1999, 213 (02) :530-536
[9]   Evaluation of adrenal masses in patients with bronchogenic carcinoma using F-18-fluorodeoxy-glucose positron emission tomography [J].
Erasmus, JJ ;
Patz, EF ;
McAdams, HP ;
Murray, JG ;
Herndon, J ;
Coleman, RE ;
Goodman, PC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (05) :1357-1360
[10]   SITES OF RECURRENCE IN RESECTED STAGE-I NON-SMALL-CELL LUNG-CANCER - A GUIDE FOR FUTURE STUDIES [J].
FELD, R ;
RUBINSTEIN, LV ;
WEISENBERGER, TH .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1352-1358
1234